World

Most ‘long Covid’ symptoms clear up in a year for mild cases: Study


PARIS – Most symptoms from “long Covid” clear up within a year for people who had mild initial infections, a large Israel study said on Thursday, with the findings welcomed as “reassuring”.

At least 17 million people in Europe suffered from long Covid-19 symptoms months after recovering from their initial infection during 2020 and 2021, according to modelling from the World Health Organisation.

However, much about the condition has remained unclear, including how long it lasts.

Researchers in Israel analysed the medical records of nearly two million people of all ages who were tested for Covid-19 in the country between March 2020 and October 2021.

The results therefore covered the earlier Covid-19 variants including Delta, but not the more recently discovered Omicron variants.

The researchers combed through the records, which were provided by Maccabi Healthcare Services, for more than 70 different symptoms that have been linked to long Covid.

They excluded patients who had more serious illness, including those who were hospitalised, which previous research has suggested have a higher risk of long Covid.

For the mild cases, the study found a significantly increased risk of several conditions, including loss of smell and taste, breathing problems, weakness, palpitations, strep throat, dizziness, and concentration and memory impairment commonly called “brain fog”.

However, most symptoms cleared up within 12 months.

“There is a small number of people still suffering from shortness of breath or weakness for a year after Covid,” said Dr Maytal Bivas-Benita, a researcher at Israel’s KI Research Institute and study co-author.

The study, published in the journal BMJ, also found that vaccinated patients had a lower risk of breathing problems – the most common symptom – compared with unvaccinated cases.

See also  只需二十分鐘就能當造物者 學習草編培養孩子創造力| Straw plaiting helps students become creative and observant

Children, meanwhile, had fewer health problems than adults, and recovered from most of them well within a year.

Dr Bivas-Benita said she was “encouraged” by the findings, particularly after fears about how long the symptoms could linger.

“The vast majority of patients will be okay after a year,” she said.



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.